PPharmacelera
Pharmacelera is a Barcelona-based deep tech company that builds computer-aided drug design software combining quantum-mechanics algorithms, machine learning and high-performance computing (its "QaiM" engine) to find and optimise molecular drug candidates. Its products include PharmScreen, exaScreen and PharmQSAR, sold via licences plus computational chemistry services to pharma, biotech, CROs and research institutes; the technology derives from 25+ years of research at the University of Barcelona. Founded in 2015 and based at the Parc Científic de Barcelona (~28 employees), it raised a €6M round in February 2026 led by Heran Partners to fund US expansion.
SectorsDrug Discovery, Computational Chemistry, Biotech Software, AI/ML, Deep Tech, HPC
Start-up MapHealthtech & Bio › R&D tools & software for life sciences
Founders
E
Enric Gibert
Co-Founder & CEO
E
Enric Herrero
Co-Founder & CTO
J
Javier Luque
Co-Founder & CSO
M
Manel López
Co-Founder & Senior Principal Scientist
Global models 4
XXtalPi
China · www.xtalpi.com ↗
Combines quantum-physics calculations, AI and high-performance computing for drug design and sells computation and services to pharma partners.
$750MComparable
SSchrödinger
United States · www.schrodinger.com ↗
Licenses physics-based computational chemistry and molecular design software, plus collaboration services, to pharma, biotech and academia.
$230MComparable
AAtomwise
United States · www.atomwise.com ↗
Runs AI-driven virtual screening and structure-based drug design for pharma, biotech and academic partners.
$174MComparable
AAqemia
France · www.aqemia.com ↗
Uses quantum-inspired physics algorithms combined with machine learning to find and optimise drug candidates for pharma partners.
$160MComparable
In the same niche 26 others
See all in the Start-ups Map →
Notes: Most funded first
Investors 8
Open as list →
CCapital Cell
capitalcell.com
CClave Capital
clavemayor.com
IInveready
inveready.com
N
Noso Capital
nosocapital.gal
A
Avançsa
avancsa.gencat.cat
HHeran Partners
B
Bio&Tech Smart Capital
TThe Collider
Funding rounds 2
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-02-18 | Series A | €6M |
Heran Partners
+3 more
|
| 2021-04 | Seed (estimated) | €1M |
Lead not disclosed
+1 more
|